Results 11 to 20 of about 1,205,134 (266)
RBA4SDS – Risk–benefit assessment for sustainable dietary shifts [PDF]
Diets are evolving to cope with the ecological transition and reduce the environmental impact of agri‐food systems. The alternatives currently available will influence the nutritional content of diets and will also change consumers' exposure to ...
Martina Pavlić, Géraldine Boué
doaj +2 more sources
Guidance on risk–benefit assessment of foods [PDF]
The EFSA Scientific Committee has updated its 2010 Guidance on risk–benefit assessment (RBA) of foods. The update addresses methodological developments and regulatory needs.
EFSA Scientific Committee +26 more
doaj +2 more sources
Background: Food is considered the predominant source of human exposure to chlorinated and brominated persistent organic pollutants (POPs). Exposure and potential sources of these compounds are less studied in adolescents.
Galia Zamaratskaia +6 more
doaj +1 more source
Background: Knowledge about the nutrient intakes and food consumption in the Nordic and Baltic countries is important for the formulation of dietary reference values (DRVs) and food-based dietary guidelines (FBDGs), as part of the Nordic Nutrition ...
Eva Warensjö Lemming, Tagli Pitsi
doaj +1 more source
The study aimed to estimate vitamin D intake and plasma/serum 25-hydroxyvitamin D (25(OH)D) concentrations, investigate determinants of 25(OH)D concentrations and compare two 25(OH)D assays.
Cecilia Nälsén +6 more
doaj +1 more source
In Germany, some digital health applications (DiHA) became reimbursable through the statutory health insurance system with the adoption of the Digital Healthcare Act in 2019.
Hendrikje Lantzsch +7 more
doaj +1 more source
Illustrating Emerging Good Practices for Quantitative Benefit-Risk Assessment: A Hypothetical Case Study of Systemic Biologic Treatments for Plaque Psoriasis [PDF]
Objectives: Quantitative benefit-risk assessment (qBRA) is a structured process to evaluate the benefit-risk balance of treatment options to support decision making.
Thokala, Praveen +15 more
core +1 more source
Quantitative Benefit-Risk Assessment in Medical Product Decision Making: A Good Practices Report of an ISPOR Task Force [PDF]
Benefit-risk assessment is commonly conducted by drug and medical device developers and regulators, to evaluate and communicate issues around benefit-risk balance of medical products.
Thokala, Praveen +22 more
core +1 more source
Quality of clinical practice guidelines approved in Peru between 2015 and 2017
Introduction: The diagnosis and management of patients with the same medical condition may vary significantly depending on the treating physician.
Oscar Steven Huapaya-Huertas +5 more
doaj +1 more source
Background: Nationally representative information on food consumption data is essential to evaluate dietary habits, inform policy-making and nutritional guidelines, as well as forming a basis for risk assessment and identification of risk groups ...
Lotta Moraeus +5 more
doaj +1 more source

